21
Shanghai Fosun
2196.HK·HKEXShanghai CNFounded 199430,000 employees
Mid CappharmaPublicOncologyImmunologyInfectious Disease
Platform: Diversified CN
Market Cap
$5B
All Drugs
3
Clinical Trials
5
Failed / Terminated
2
FDA Approved
0
Stock Price & Catalysts (2196.HK)
Loading 2196.HK stock data...
Drug Pipeline (3 programs)
| Drug Name | Code | Phase | Trials | Modality | Target | MOA | Indications |
|---|---|---|---|---|---|---|---|
| Gelizumab | 219-7935 | Phase 1/2 | 2 | PI3Kα | FSGSNarcolepsy | ||
| 219-5261 | 219-5261 | Phase 3 | 2 | Tau | Ovarian CaADHD | ||
| Gozetenlimab | 219-5858 | NDA/BLA | 1 | Tau | SCD |
SEC Filings & Financial Documents
SEC filings are not available for HKEX-listed companies.
Shanghai Fosun trades on HKEX (CN). SEC EDGAR only covers US-listed issuers.
Insider Trading Activity
Insider trading data is not available for non-US exchanges.
Catalyst Events (4)